Sundong Jang
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea.
Journal: Infection & chemotherapy
Published: August 09, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.
Journal: Frontiers in cellular and infection microbiology
Published: May 19, 2022
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: August 09, 2021
Development of an attenuated smallpox vaccine candidate: The KVAC103 strain.
Journal: Vaccine
Published: October 19, 2020
Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccine.
Journal: Virology
Published: May 19, 2020
Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone.
Journal: Scientific reports
Published: February 16, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026